Study of Chemotherapy With or Without Hepatic Arterial Infusion for Patients With Unresectable Metastatic Colorectal Cancer to the Liver
The purpose of this study is to see if patients treated with both regional chemotherapy using the HAI pump and intravenous chemotherapy are able to have their liver tumors removed surgically (resected), versus treatment with only intravenous chemotherapy.
Colorectal Adenocarcinoma Metastatic to the Liver
DRUG: Floxuridine (FUDR)|DRUG: Irinotecan (CPT-11)|DRUG: FLUOROURACIL|DRUG: PANITUMUMAB|DRUG: DEXAMETHASONE|DRUG: Leucovorin
Resection rate assessed using RECIST (version 1.1), Treatment evaluation will be done using RECIST (version 1.1) The patient will be assessed with repeat CT scans as specified. If at any time after 3 cycles (or 3 months) the patient is able to undergo a complete resection of all hepatic metastases they will proceed to operative assessment., 3 months
The purpose of this study is to see if patients treated with both regional chemotherapy using the HAI pump and intravenous chemotherapy are able to have their liver tumors removed surgically (resected), versus treatment with only intravenous chemotherapy.